From the 2nd European CAR T-cell Meeting in Sitges, Spain, Ulrich Jäger, MD, Medical University of Vienna, Vienna, Austria, outlines a country-wide selection algorithm that is being implemented in order to better select appropriate patients for CAR T-cell therapy. The advent of common scientific programs has also enabled patients to get easier access to clinical studies amongst other benefits.
From the 2nd European CAR T-cell Meeting in Sitges, Spain, Ulrich Jäger, MD, Medical University of Vienna, Vienna, Austria, outlines a country-wide selection algorithm that is being implemented in order to better select appropriate patients for CAR T-cell therapy. The advent of common scientific programs has also enabled patients to get easier access to clinical studies amongst other benefits.
![Zilent - Matter of Fact of Bitter Life [Explicit] Ft. $UAZO](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_tBhfTufpUNdUVZbbLJWvj9MNEUU2SsQCT2o62RIexE4POvBKoIik8IzVJqQhSdgX2IH-SvbLq80Z98iAYwUMceZzk_OauUBgrbqz-qmZoh5JnlKQ=w680)
0 Comments